ANDA 89047, held by Novartis. Sulfacetamide Sodium.
As of Nov 15, 2026, ANDA 89047 (Sulf-15), held by Novartis, was first approved by FDA on Oct 31, 1995, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 31, 1995 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Sulf-1515% ยท solution/drops;ophthalmic | Sulfacetamide Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
